Additionally, galectin-3 IHC expression is decreased in SCLC when compared to NSCLC, and studies have demonstrated that higher serum and tumor levels of galectin-3 in NSCLC are associated with lymph node metastasis and tumor recurrence [23,24,25]. The gene discussed is LGALS3; the disease is metastatic malignant neoplasm in the lymph nodes.